RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles

Displaying items 45-55
  • Glaxo Settles Avandia Lawsuits for $460 Million

    Glaxo Settles Avandia Lawsuits for $460 Million
    GlaxoSmithKline agreed to pay about $460 million to resolve a majority of lawsuits alleging the company's Avandia diabetes drug can cause heart attacks and strokes, people familiar with the accords said. Glaxo, the U.K.'s biggest drugmaker, agreed to...
  • The Avandia Dilemma

    The Avandia Dilemma
    The arthritis pill Vioxx was withdrawn but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on. So, when is a drug too risky to stay on the market? Drug safety...
  • For Diabetes Drug Avandia, Bad News Continues

    For Diabetes Drug Avandia, Bad News Continues
    The diabetes drug Avandia, once the world's top-selling diabetes medication, took two more hits Monday with one new study linking it to an increased risk of heart attacks and a separate study linking it to an increased risk of heart failure and stroke....
  • Experts Vote to Keep Avandia

    Experts Vote to Keep Avandia
    U.S. health advisers said GlaxoSmithKline Plc's GSK.L diabetes drug Avandia should be allowed to stay on the market in some form, easing a threat of further litigation that could have followed a ban. The 33-member panel of outside experts convened by the...
  • FDA: Avandia Should Stay With Restrictions

    FDA: Avandia Should Stay With Restrictions
    Faced with conflicting and less-than-conclusive scientific evidence, a Food and Drug Administration advisory panel recommended Wednesday that the controversial diabetes drug Avandia remain on the market — but with tighter supervision and increased...
  • Glaxo adds safety restrictions to Avandia label

    Glaxo adds safety restrictions to Avandia label
    WASHINGTON (AP) -- GlaxoSmithKline PLC said Monday it has updated the labeling of its diabetes pill Avandia to include safety restrictions ordered by federal health authorities because of the drug's links to heart attack. The Food and Drug Administration...
  • Men taking erectile dysfunction drugs risk STDs

    Men taking erectile dysfunction drugs risk STDs
    Men who took erectile dysfunction drugs such as Viagra were more likely to become infected with sexually transmitted diseases, including AIDS, U.S. researchers have reported. This infection rate was higher even in the year before the men got their...
  • Glaxo Removing Zinc From Denture Cream

    Glaxo Removing Zinc From Denture Cream
    WASHINGTON (AP) - GlaxoSmithKline said Thursday it will remove zinc from its denture cream, following reports that excessive use over many years can cause neurological damage and blood problems in consumers. The British manufacturer will cease...
  • High hopes for a malaria vaccine

    Each year, malaria kills more than 1 million people -- 90% of them in sub-Saharan Africa and 80% of them younger than 5 -- and makes 300 million people seriously ill. Major progress in controlling the disease has been made by the widespread adoption of...
  • Genital warts tied to range of cancers

    Genital warts tied to range of cancers
    NEW YORK (Reuters Health) - People who've ever had genital warts may have a somewhat higher risk of several types of cancer — possibly including common skin cancers, a new study suggests. The findings, reported in the Journal of Infectious...
  • Human Genome Sciences rebuffs $2.6 billion offer from GlaxoSmithKline

    Shares of Human Genome Sciences doubled in Thursday morning trading on news that a major British biopharmaceutical company offered to buy it for $2.6 billion, which the Rockville company rejected as too low. Human Genome, which uses the human DNA...